Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
3.49
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E- EPS (ttm)-1.64 Insider Own48.08% Shs Outstand43.59M Perf Week-5.93%
Market Cap222.49M Forward P/E- EPS next Y-0.80 Insider Trans4.92% Shs Float33.10M Perf Month3.25%
Income-60.18M PEG- EPS next Q-0.15 Inst Own37.37% Short Float2.15% Perf Quarter-5.42%
Sales0.00M P/S- EPS this Y75.02% Inst Trans1.77% Short Ratio2.95 Perf Half Y-13.40%
Book/sh1.40 P/B2.49 EPS next Y-54.12% ROA-76.37% Short Interest0.71M Perf Year-47.36%
Cash/sh1.41 P/C2.48 EPS next 5Y- ROE-115.90% 52W Range2.00 - 7.63 Perf YTD-25.27%
Dividend Est.- P/FCF- EPS past 5Y- ROI-98.64% 52W High-54.28% Beta0.15
Dividend TTM- Quick Ratio6.17 Sales past 5Y0.00% Gross Margin- 52W Low74.50% ATR (14)0.32
Dividend Ex-Date- Current Ratio6.17 EPS Y/Y TTM-867.93% Oper. Margin0.00% RSI (14)42.42 Volatility7.62% 8.85%
Employees15 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price17.80
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q99.43% Payout- Rel Volume2.53 Prev Close3.49
Sales Surprise- EPS Surprise91.40% Sales Q/Q- EarningsMay 09 BMO Avg Volume240.93K Price3.49
SMA20-1.62% SMA50-18.42% SMA200-16.41% Trades Volume609,347 Change0.00%
Date Action Analyst Rating Change Price Target Change
May-03-24Initiated Piper Sandler Overweight $26
Oct-10-23Initiated Ladenburg Thalmann Buy $10
Aug-25-23Initiated Oppenheimer Outperform $17
Jun-22-23Initiated Guggenheim Buy $20
Jun-14-23Initiated Chardan Capital Markets Buy $14
May-24-23Initiated Raymond James Strong Buy $20
Jul-12-24 06:10AM
06:08AM
Jun-14-24 06:00AM
Jun-06-24 06:00AM
Jun-03-24 06:00AM
09:55AM Loading…
May-31-24 09:55AM
May-29-24 06:00AM
May-24-24 06:18AM
May-15-24 09:55AM
May-14-24 12:00PM
May-12-24 03:26PM
May-10-24 03:14PM
May-09-24 01:56PM
06:00AM
Apr-25-24 02:18AM
09:22AM Loading…
Apr-18-24 09:22AM
Apr-08-24 06:00AM
Mar-28-24 11:54AM
06:00AM
Mar-04-24 06:00AM
Feb-02-24 06:00AM
Jan-08-24 06:00AM
Jan-03-24 06:00AM
Dec-04-23 06:00AM
Nov-14-23 06:00AM
Nov-13-23 06:30AM
Sep-12-23 05:00AM
Sep-05-23 08:55PM
Aug-25-23 09:42AM
Aug-14-23 07:00AM
06:30AM Loading…
Jun-23-23 06:30AM
Jun-06-23 06:34AM
04:00AM
Jun-01-23 10:20AM
Apr-27-23 07:39AM
Apr-14-23 05:00AM
Mar-27-23 09:35AM
Mar-21-23 06:13AM
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ploos van Amstel ArnoutDirectorMay 17 '24Buy6.2080,000496,000100,000May 23 08:53 AM
Sidhu SomeitDirectorApr 22 '24Buy3.131,186,9013,715,0001,186,901Apr 24 06:51 PM
Munshi AmitDirectorApr 22 '24Buy3.13159,744499,999777,384Apr 24 06:52 PM
Howell MichaelSee RemarksApr 22 '24Buy3.137,98724,9997,987Apr 24 06:54 PM
Nistala KiranExecutive Vice PresidentApr 22 '24Buy3.133,19510,0003,195Apr 24 06:53 PM
Thiara ParvinderDirectorDec 12 '23Sale4.002,000,0008,000,0004,801,633Dec 14 03:35 PM